About Shaanxi Micot Technology
Shaanxi Micot Technology is a company based in China founded in 2007 by Wang Bing. Shaanxi Micot Technology has raised $72.16 million across 2 funding rounds from investors including Tasly, NLVC and Detong Capital. Shaanxi Micot Technology operates in a competitive market with competitors including Enzene Biosciences, Hybio Pharmaceutical, AmbioPharm, Ocelot Bio and vivitide, among others.
- Headquarter China
- Founders Wang Bing
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$72.16 M (USD)
in 2 rounds
-
Latest Funding Round
$55.92 M (USD), Series B
May 21, 2021
-
Investors
Tasly
& 2 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Shaanxi Micot Technology
Shaanxi Micot Technology has successfully raised a total of $72.16M across 2 strategic funding rounds. The most recent funding activity was a Series B round of $55.92 million completed in May 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Shaanxi Micot Technology
Shaanxi Micot Technology has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include Tasly, NLVC and Detong Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Provider of early stage venture capital focused on technology companies
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked | |
|
Traditional Chinese medicines are manufactured and distributed globally.
|
Locked | Locked | Locked |
Investor details for Shaanxi Micot Technology
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Shaanxi Micot Technology
Investment portfolio details for Shaanxi Micot Technology
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Shaanxi Micot Technology
Detailed financials for Shaanxi Micot Technology
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Shaanxi Micot Technology Comparisons
Peer comparison for Shaanxi Micot Technology
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Shaanxi Micot Technology
Shaanxi Micot Technology operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Enzene Biosciences, Hybio Pharmaceutical, AmbioPharm, Ocelot Bio and vivitide, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Company specializing in development of Biosimilars
|
|
| Locked | Locked | Locked |
Polypeptide drugs and APIs are developed and manufactured.
|
|
| Locked | Locked | Locked |
CDMO and analytical services for peptide development are provided.
|
|
| Locked | Locked | Locked |
Ocelot Bio is a CDMO specializing in peptide manufacturing services.
|
|
| Locked | Locked | Locked |
Drug development services for neoantigen peptides and antibodies are provided.
|
|
| Locked | Locked | Locked |
Industrial and therapeutic proteins are manufactured by Aperiam Bio.
|
Detailed competitors of Shaanxi Micot Technology
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Shaanxi Micot Technology
Complete news archive for Shaanxi Micot Technology
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Shaanxi Micot Technology
Shaanxi Micot Technology was founded in 2007 and raised its 1st funding round 12 years after it was founded.
Shaanxi Micot Technology is headquartered in China.
Shaanxi Micot Technology is a funded company, having raised a total of $72.16M across 2 funding rounds to date.
Shaanxi Micot Technology was established in 2007 in China. Drug research and development services are offered, targeting cardiovascular and metabolic diseases within the pharmaceutical sector. Operations involve support for drug discovery, preclinical studies, and related processes. Expertise is applied to address unmet needs in these therapeutic areas, with activities based primarily in the Chinese market. Leadership is provided by founder Wang Bing as chairman and president.
Shaanxi Micot Technology's top competitors include Enzene Biosciences, Hybio Pharmaceutical and AmbioPharm.